US20070073160A1 - Light-guided transluminal catheter - Google Patents

Abstract

Generally, the present invention is directed to a light-guided catheter for direct visualization of placement through the skin. An embodiment of the invention includes a method for transcutaneous viewing and guiding of intracorporeal catheters into a body that comprises inserting a catheter into the body having at least one lumen and internally illuminating the catheter with light capable of propagating through the blood and tissue to an external viewer outside of the body.

Description

FIELD OF THE INVENTION
• The present invention is directed generally to medical devices and more particularly to a light-guided catheter with inside-out transcutaneous illumination and visualization of placement through the skin including a method to locate non-visible blood vessels for catheterization.
BACKGROUND
• Generally to insert a catheter into a blood vessel, the vessel is initially identified via aspiration by a syringe with an attached hollow needle by a technique commonly referred to as the Seldinger technique. When blood is drawn into the syringe this indicates that the vessel has been found. The syringe is then disengaged from the needle and the needle lumen is occluded to prevent a possible air embolism and/or to prevent excessive bleeding. Thereafter, confirmation of needle placement in the vein or artery can be assured by haemodynamic monitoring or checking for pulsatile blood flow. Then, a thin guide wire is introduced, typically through the syringe needle or other introducer device, into the interior of the blood vessel. The needle/introducer device is then withdrawn leaving the guide wire within the vessel, wherein the guide wire projects outwardly beyond the surface of the skin.
• At this point, several options are available to a physician for catheter placement. The simplest is to pass the catheter directly into the blood vessel directly over the guide wire. The guide wire is then withdrawn, leaving the catheter in position within the vessel. Correct catheter tip placement may then be verified by x-ray procedures. However, this technique is only possible in cases where the catheter is of a relatively small diameter and not significantly larger than the guide wire. If the catheter to be inserted is significantly larger than the guide wire, a dilator device may be first passed over the guide wire to enlarge the insertion hole. The catheter is then introduced over the dialator/guide wire, and the guide wire and dilator are withdrawn.
• The technique may be rather routine and straightforward in cases where the patient's blood vessel is near the surface of the skin and is directly visible. However, there are patients (especially the elderly and newborns) wherein their blood vessels are not easily visible and the initial needle puncture may default to a hunt-and peck routine to find the elusive vessel. Even more, once the elusive vessel is found, the insertion of the catheter is usually a blind procedure with verification of correct catheter tip placement only confirmed after the fact by radiographic methods.
• Given this, there is a need for a technique to visualize and/or identify the relative location of non-visible blood vessels for initial catheter entry and subsequent real-time visualization while guiding the catheter for correct tip placement.
SUMMARY OF THE INVENTION
• Generally, the present invention is directed to medical devices and more particularly to a light-guided catheter with inside-out transcutaneous illumination and visualization of placement through the skin for the purpose of allowing real-time visual guidance, including a method to locate non-visible blood vessels for catheterization.
• One particular embodiment of the invention is directed to a method for transcutaneous viewing and guiding of intracorporeal catheters into a body that comprises inserting a catheter into the body having at least one lumen and internally illuminating the catheter with light capable of propagating through the blood and tissue to an external viewer outside of the body.
• Another embodiment of the invention is directed to a method for transcutaneous viewing and guiding of intracorporeal catheters into a body that comprises inserting a catheter into the body having at least one lumen and inserting into the lumen a source of illumination capable of propagating through the blood and tissue to an external viewer outside of the body.
• Another embodiment of the invention is directed to a method for transcutaneous viewing and guiding of intracorporeal/intraarterial catheters wherein the internally illuminated catheter emits light of a first color and further includes the step of inserting into the catheter lumen a second source of illumination of a second color different from the first color, both of the colors being capable of propagating through blood and tissue to an external viewer outside of the body, whereby the location of each illumination source can be discerned from outside the body.
• Another embodiment of the invention is directed to a method for transcutaneous viewing and guiding of intracorporeal/ catheters wherein the internally illuminated catheter is made of a material opaque to visible light and the light emitting device extends beyond the distal end of the catheter.
• Another embodiment of the invention is directed to a method of locating non-visible intracorporeal/ blood vessels for catheterization comprising illuminating candidate locations with light capable of inducing fluorescence from blood constituents and detecting fluorescent response from the blood constituents thereby selecting the potential site for catheterization based upon detection of a predetermined fluorescent signal.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter comprising a tubular member having an insertable end and a first channel along the length of the catheter. The catheter has a removable illumination source in said channel having at least an illuminated end, the source being configured to be extendible through said channel and beyond said end so that when the source is inserted into the channel, the illumination is visible outside the body, and the end thereof can be visually located.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter wherein the tubular member is substantially opaque to light from the illumination source; so that when the removable source is extended beyond the end of the member, the illumination is visible outside the body.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter wherein the tubular member is partially transparent to light emitted by the illumination source; so that when the illumination source reaches the end of tubular member, an observer can detect the difference in level or color of light transmission as the illumination source exits the tubular member.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter wherein the illumination source is leaky and emits light along at least a portion of its length, whether discrete or continuous.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter wherein the illumination source emits more light at its end than elsewhere therealong, so that it is possible to easily discern its path and end from outside the body.
• Another embodiment of the invention is directed to an apparatus for locating substantially non-visible intracorporeal/blood vessels for catheterization comprising a tubular member having an insertable end and a channel along the length thereof. The apparatus has a removable illumination source insertable in the channel having an illuminated end configured to be extendible through the channel. The illumination source is capable of emitting light of predetermined optical wavelengths to excite fluorescence from blood constituents including an optical channel to receive fluorescence from blood constituents and an optical detector coupled to the optical channel to measure the fluorescence from the blood constituents. This embodiment could be incorporated into all other embodiments for facilitation of initial vessel identification and placement prior to catheter insertion and final optimization of final tip placement.
• Another embodiment of the invention is directed to an apparatus for locating substantially non-visible intracorporeal/ blood vessels for catheterization wherein an appropriate illumination source would be used, such as a low-loss fiber optic conductor or light-emitting diode.
• Another embodiment of the invention is directed to an apparatus for locating substantially non-visible intracorporeal/ blood vessels for catheterization wherein the optical channel simultaneously delivers the illumination energy to excite fluorescence and receives fluorescence from blood constituents.
• Another embodiment of the invention is directed to an apparatus for locating substantially non-visible intracorporeal/ blood vessels for catheterization wherein the optical components include a separator, such as but not limited to a dichroic mirror, to separate illumination and fluorescence signals prior to the optical detector.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter comprising a tubular member having an insertable end and a first channel along the length of the catheter, with a first optic having an end and being formed within the tubular member and running substantially the length thereof. At least a portion of the first optic is leaky and an illumination source is connected to the optic to provide illumination at least along a portion of the length of the catheter with an optimized color of light so that the illumination is visible outside the body.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter comprising a tubular member having an insertable end and a channel along the length of the catheter, with a first optic embedded within the tubular member and running substantially the length thereof and a second optic inserted into the catheter channel and running substantially the length thereof. At least a portion of both optics are leaky and separate illumination sources of distinguishable colors or intensities are connected to each optic so that when both are illuminated the location of the end of the second optic can be distinguished from the first optic.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter comprising a tubular member having an insertable end and a channel along the length of the catheter, with a first optic embedded within the tubular member and running substantially the length thereof and a second optic inserted into the catheter channel and running substantially the length thereof. At least a portion of both optics are leaky, the second optic being leaky only near its end, and separate illumination sources of distinguishable colors are connected to each optic so that when both are illuminated the location of the end of the second optic can be distinguished from the first optic.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter comprising a tubular member having a first and second optic embedded within the tubular member and running along the length of the catheter. At least a portion of both optics are leaky, the second optic being leaky proximate its end, and separate illumination sources of distinguishable colors are connected to each optic so that when both are illuminated the location of the end of the second optic can be distinguished from the first optic.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter comprising a tubular member having an insertable end and a first channel along the length of the catheter, with a first optic having an end and being formed within the tubular member and running substantially the length thereof. At least a portion of the first optic is leaky and an illumination source is connected to the optic to provide illumination at least along a portion of the length of the catheter with a predetermined color of light so that the illumination is visible outside the body. The catheter further includes an enlongated radio opaque element having an end and being insertable through the first channel, so that the location of the end of the elongated element can be distinguished from the first optic and detected from outside the body.
• Another embodiment of the invention is directed to a transcutaneously viewable catheter comprising a tubular member having a first and second optic embedded within the tubular member and running along the length of the catheter. At least a portion of both optics are leaky, the second optic being leaky proximate to its end, and separate illumination sources of distinguishable colors are connected to each optic so that when both are illuminated the location of the end of the second optic can be distinguished from the first optic. The catheter further includes an enlongated radio opaque element having an end and being insertable through the first channel. In this manner, the location of the end of the elongated element can be detected either visually via fluorescence using the light-emitting optic, or by radio detection (X-ray fluoroscopy techniques) if the optic has been removed.
• The above summary of the present invention is not intended to describe each illustrated embodiment or every implementation of the present invention. The figures and the detailed description which follow more particularly exemplify these embodiments.
BRIEF DESCRIPTION OF THE DRAWINGS
• The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
• FIG. 1 shows a schematic representation of an optically opaque multi-lumen catheter device inserted into a patient's blood vessel with a fiber optic device inserted into a working channel of the catheter providing inside-out transcutaneous illumination near the distal end of the catheter.
• FIG. 2 shows a schematic representation of an optically transparent multi-lumen catheter device inserted into a patient's blood vessel with a fiber optic device inserted into a working channel of the catheter providing inside-out transcutaneous illumination along the length of the catheter.
• FIG. 3A shows a side-view of a multi-lumen catheter device with a fiber optic inserted into a working channel of the catheter wherein the catheter device is delivering optical radiation to the patient's blood vessel and receiving a fluorescent signal back from chemistry constituents within the patient's blood.
• FIG. 3B is an enlargement of the fiber optic device depicted inFIG. 3A, highlighting the counter propagating excitation and fluorescent optical signals traversing the fiber optic device.
• FIG. 4 is a top view (looking down) of the catheter device shown inFIG. 3A showing the catheter device laterally displaced from the underlying patient's blood vessel.
• FIG. 5 is a top view (looking down) of the catheter device shown inFIG. 3A showing the catheter device directly centered over the underlying patient's blood vessel.
• While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
DETAILED DESCRIPTION
• In general, the present invention is directed to medical devices and more particularly to a light-guided catheter for direct visualization of placement through the skin. The catheter may be placed intracorporeal (inside the body) by any of the catheterization techniques known to those skilled in the art, and the invention includes, but is not limited to intravenous, intraarterial, or intraluminal placement of the catheter.
• One embodiment of a light-guidedtransluminal catheter device100 is depicted schematically inFIG. 1. Amulti-lumen catheter102 is shown having been inserted through the patient'sskin104 and into theblood vessel lumen106 over theguidewire108 via the usual insertion techniques (e.g., the Seldinger technique mentioned earlier). A similar catheter without initial guidewire may also be inserted directly through the lumen of the puncturing needle. This is commonly done in the case of peripherally-inserted central catheters (PICC) inserted in an extremity such as the arm or leg and threaded all the way to the heart.
• Prior to insertion into the patient'sblood vessel lumen106 throughblood vessel wall107, the surgeon may insert a fiberoptical device110 into an available workingchannel112 of themulti-lumen catheter102. Alternatively, thefiber optic device110 may be used in lieu of the guidewire following the Seldinger technique described earlier. In this approach, thefiber optic device110 is inserted through the hypodermic needle and thecatheter102 is introduced into the patient's blood vessel by sliding the catheter over thefiber optic device110. The fiberoptical device110 may comprise a plurality of “leaky” optical fibers or other light radiating structures which may extend from the exposedend114 of thecatheter102 to slightly protruding outward from thedistal end116 of thecatheter102 into the patient'sblood vessel lumen106. By leaky, we refer to those optical fibers which radiate or scatter light energy radially outward continuously along at least a portion of the length, i.e. the lateral surface of the fiber. In the preferred embodiment, light emitted would preferably be in the visible light range so that special detection equipment is not required. Illuminating at least a portion of the length of the catheter is desirable, for example, when inserting the catheter it may be highly advantageous to “see” the lateral surface of the catheter when navigating a bend or curve in the patient's blood vessel, which is not uncommon when inserting an intracardiac or “central” catheter from a peripheral location, as in PICC (peripherally inserted central catheter) placement at a distal extremity and threaded toward the heart. In this configuration, the physician may get direct visual confirmation that the catheter is proceeding smoothly “around the bend” without complications. This should be interpreted to mean that a portion of the lateral surface of the catheter, which will be inserted into the body, is capable is emitting illumination. Illumination merely at the tip of the catheter would not be considered to be a portion along the length or lateral surface thereof since the tip is not reasonably considered to be “a length”. Likewise, the entire length thereof should be interpreted broadly so as to encompass less than every millimeter of the length, but much of the length which is inserted into the body so that the full pathway can be detected.Light emitting devices113 may be optically coupled to theoptical fibers110 by means well known in the art of optical communications. For example,light output111 from thelight emitting devices113 may be coupled into theoptical fiber110 via a focusinglens115 or other light coupling components. Thelight emitting devices113 may be chosen from the list of lasers, light emitting diodes, tungsten-halogen lamps or other suitable light sources with appropriate optical wavelength outputs to be visible by the naked eye or an opto-electronic detector. In the case where opto-electronic detectors are used which may be sensitive to non-visible wavelengths (infrared, ultraviolet, etc.) appropriate alternative light sources and optical fibers may be utilized to generate, guide, and ultimately detect non-visible wavelengths emanating from the fibers.
• With respect to the wavelengths of light that have worked best with the catheters, many of them are suitable. The main differences lie in the penetrance of immediate and adjacent tissues, in which the red wavelengths seem to be the most effective (˜625-680 nm), but 532 nm (green) also works sufficiently. This general wavelength has the advantage of minimizing the amount of scattering and provides for more precise catheter localization as would the red range at, for example, 5 milliwatts (mw) of power.
• Therefore, preferred embodiments might include green (532 nm) and/or red (635 nm) wavelength light sources coupled to the optic, which in preliminary experiments in rabbits and neonatal humans have been able to penetrate >1 cm of tissue and therefore would be visible to the naked eye at depths of up to 1 cm below the skin surface with relatively low light power (<5 mw).
• In short, visible light is highly advantageous because no special detection equipment is needed other than perhaps dimming of the ambient room light, which is already routinely practiced in the ICU environment with traditional venous transilluminators to identify vessels for venipuncture and/or arterial puncture.
• In the embodiment depicted inFIG. 1, theouter surface118 of themulti-lumen catheter device102 may be optically opaque so that onlyoptical radiation119 emanating from that portion of the optical fiber protruding from the distal end of thecatheter116 may propagate outward through theluminal blood106/skin104 regions ultimately to the surgeon'seyes120 for direct viewing of the in-dwelling location of the catheter tip region116 (this region being defined as the tip itself and a portion of the catheter extending away from the tip so that a sufficient portion of the catheter can be easily detected. By illuminating only the tip, (essentially a point source) the possibility of an error in detection or reading is increased. This is avoided by illuminating a region adjacent the tip simultaneously. Thelight emitting devices113 may be operated continuously, intermittently, or in pulsatile fashion to facilitate visibility through theluminal blood106/skin104 regions. Given this, the physician may visually track the location of the distal end region of thecatheter116 as the catheter is maneuvered further upstream in the patient'sblood vessel lumen106 towards the ultimate targeted location. Alternatively, the physician may insert the fiberoptical device110 after thecatheter102 is initially inserted into the patient'sblood vessel lumen106 and guide thecatheter102 by viewing the illuminateddistal tip116 as mentioned above.
• Analternative embodiment200 of the present invention is depicted schematically inFIG. 2. Amulti-lumen catheter202 is shown having been inserted through the patient'sskin204 and into theblood vessel206 over theguidewire208 via the usual insertion techniques (e.g., the Seldinger technique mentioned earlier).
• Prior to insertion into the patient'sblood vessel206, the surgeon may insert a fiberoptical device210 into an available workingchannel212 of themulti-lumen catheter202. The fiberoptical device210 may consist of a plurality of “leaky” optical fibers or other light radiating structures which may extend from the exposedend214 of thecatheter202 to slightly protruding outward from thedistal end216 of thecatheter202 into the patient'sblood vessel206. By leaky, we refer to those optical fibers which radiate or scatter light energy radially outward continuously along the length of the fiber.Light emitting devices213 may be optically coupled to theoptical fibers210 by means well known in the art of optical communications. Thelight emitting devices213 may be chosen from the list of lasers, light emitting diodes, tungsten-halogen lamps or other suitable light sources with appropriate optical wavelength outputs to be visible by the naked eye.
• In the embodiment depicted inFIG. 2, theouter surface218 of themulti-lumen catheter device202 may be partially, segmentally, or entirely optically transparent so thatoptical radiation219 emanating from the optical fiber may propagate outward along the entire length of the fiber/catheter through theblood206/skin204 regions ultimately to the surgeon'seyes220 for direct viewing of the in-dwelling location of thecatheter202. Theouter surface218 may also modify the intensity, scatter, or wavelength of light passing through it such that the observer or detector would be able to discern the portion of the optic fiber extruded past the catheter tip from the potion lying within it. Given this, the physician may visually track the location of the entire length of thecatheter202 as the catheter is maneuvered further upstream in the patient'sblood vessel206 towards the ultimate targeted location. Alternatively, the physician may insert the fiberoptical device210 after thecatheter202 is initially inserted into the patient'sblood vessel206 and guide thecatheter202 by viewing the illuminated catheter as mentioned above. In an alternative embodiment, thefiber optic device210 may be inserted into an available workingchannel212 of themulti-lumen catheter202 as before, however, in this case prior to patient insertion the fiber end-face may be withdrawn a sufficient distance back into thedistal end216 of the catheter such that only thelateral surface218 of the catheter is illuminated. This configuration may eliminate the possibility of the fiber end-face irritating the wall of the patient's blood vessel as the catheter is being inserted, while still illuminating through the lateral surface of a translucent or otherwise non-opaque catheter, thelateral surface218 of thecatheter202 during insertion and final placement.
• In situations where the physician threading the catheter is particularly interested in the location of the catheter tip, the physician may utilize two individualoptical fibers210 to achieve this result. For example, one fiber may be either be pre-loaded into thecatheter202 flush with thedistal end216 of thecatheter202 or the fiber may be embedded in the wall of thecatheter202 terminating at thedistal end216 of thecatheter202. This fiber may be “leaky” along its length and when coupled with a blueLED light source213, for example, it may illuminate the entire sidewall of thecatheter202 with a blue tint, seen transcutaneously. A second “non-leaky” optical fiber may be inserted into a working lumen of thecatheter202 and may be coupled to a green LED. As the second fiber is inserted intocatheter202 and slightly beyond thedistal end216 of thecatheter202 the transition from blue to green seen transcutaneously may serve as a marker identifying the location of thedistal tip216 of thecatheter202. Of course, different color light sources than the blue/green pair outlined above may be utilized to achieve similar results, wherein in all cases it is preferred that the light sources generate light visible to the naked eye.
• An alternative embodiment to locate thedistal tip216 of thecatheter202 incorporates embedding two separate optical fibers in the wall of thecatheter202. Similar to the above embodiment, the first optical fiber may be embedded in the wall of thecatheter202 terminating at thedistal end216 of thecatheter202. The first fiber may be “leaky” along its length and when coupled with a blueLED light source213, for example, it may illuminate the entire sidewall of thecatheter202 with a blue tint, seen transcutaneously. A second “non-leaky” (i.e., optical energy only radiating from the distal end) fiber may also be imbedded in the wall of thecatheter202 terminating approximately an inch from thedistal end216 of thecatheter202 and may be coupled to a green LED. In this configuration, the transition from a pure blue transcutaneous tint to a blue/green mixture may identify the location of thedistal end region216 of theintracorporeal catheter202. As before, different choices for the light sources may lead to acceptable alternative color combinations for transcutaneous viewing such as blue/white, green/white, yellow/blue and the like.
• Another embodiment of the present invention comprises the combination of a fiber-illuminated catheter used in tandem with a traditional radio-opaque wire used in X-ray fluoroscopy. In this embodiment a single or multiple lumen catheter may have the illuminating and/or radio-opaque fiber either embedded in the wall of the catheter or inserted in an available catheter lumen as before. The radio-opaque wire may be inserted into a vacant catheter lumen or inserted into the same lumen as the illuminating fiber. The illuminating fiber itself may also be radio-opaque (though another embodiment includes a radio-opaque fiber which will both provide propagation of light when connected to a source of illumination, but also be visulizable on radiographs) In this configuration, the physician may multiplex back and forth between the two approaches as necessary. For example, an initial entry into the radial artery (arm) destined for the cardiac region may proceed as follows. Initial entry and threading in the arm may be guided directly by transcutaneous viewing of the fiber-illuminated catheter as outlined before. Upon entry into the chest cavity region, the physician may choose to switch to standard X-ray fluoroscopy when and if the visibility of the fiber-illumination becomes too faint to discern.
• Another embodiment of the present invention encompasses a dual-purpose function of the illuminating fiber. In this embodiment the illuminating optical fiber is inserted into an available lumen and illuminates the distal end of the catheter as previously outlined. In addition the fiber may have optically excited chemical sensors attached to the distal end of the fiber. For example, fluorescent dyes sensitive to the dissolved oxygen in blood (sometimes referred to as the partial pressure of oxygen in blood and designated as pO₂) are well known and historically have been encapsulated in a polymer membrane attached to the distal end of the sensing fiber. Similarly, additional fluorescent dyes have been demonstrated to respond to the dissolved carbon dioxide in blood (pCO₂) as well as the acidity (pH) of blood. The trio above, pO2, pCO2, and blood pH are commonly referred to as a “blood gas” measurement in a hospital setting. A detailed explanation of the mechanism involved for optically sensing “blood gases” by way of fluorescent chemical sensors/dyes attached to the distal end of an optical fiber can be found in U.S. Pat. No. 5,672,515 titled “Simultaneous Dual Excitation Single Emission Fluorescent Sensing Method For pH and pCO₂” which is incorporated herein by reference. The additional ability to measure one or more of the “blood gases” while simultaneously viewing the illuminated catheter transcutaneously may allow the physician sufficient information to ascertain whether the catheter has been threaded into arterial or mixed venous blood, given that typical blood gas measurements for venous blood is discernibly different than arterial values.
• The above embodiments may also be particularly useful in the placement of peripherally-inserted central catheters (commonly referred to as PICC lines), as well as umbilical artery and vein catheters used in the neonatal intensive care units. PICC lines are commonly introduced into the patient's arm or leg through the lumen of the puncturing needle and threaded all the way to the patient's heart. The PICC lines are subject to being misrouted when inserted and guided (threaded) blindly, and with direct transcutaneous viewing of the catheter while threading, this may be alleviated. The direct transcutaneous viewing of the catheter while threading may be ideal for newborn infants with inherently thin skin, and may also be applicable to a large segment of the adult population, especially the elderly.
• An alternative embodiment of the present invention is depicted schematically inFIGS. 3A and 3B.FIG. 3A shows acatheter300 configured to function as an artery or vein-finder device to optically locate blood vessels which may not be visible directly by the unaided eye. A side view of amulti-lumen catheter302 is shown in contact with a patient'sskin304 directly over the patient'sblood vessel306. Anoptical fiber310 has been inserted into an available workingchannel312 of thecatheter302. Theoptical fiber310 may be similar to those currently used in optical communications (i.e., “non-leaky” in contrast to the “leaky” fibers depicted inFIGS. 1 and 2) with the ability to waveguide light over long distance with minimal loss out the lateral surface.Light emitting devices313 may be optically coupled to theoptical fibers310 by means well known in the art of optical communications. Thelight emitting devices313 may be chosen from the list of lasers, light emitting diodes, tungsten-halogen lamps or other suitable light sources with appropriate optical wavelength outputs to excite optical fluorescence from chemistries in the underlying blood vessel. In this configuration, thecatheter302 with inserted optics to excite and receive fluorescent signals from chemistries in the underlying blood vessel, may serve as an artery/vein finder to identify the correct location for the initial needle stick (first step in Seldinger technique or in PICC placement) to facilitate the process of eventually placing the catheter in-dwelling. A detailed explanation of the optical technique is described below.
• Naturally occurring chemistries in human blood are well known to fluoresce when excited (illuminated) at a particular wavelength corresponding to the absorption band of that chemistry. During the subsequent fluorescence process (which usually occurs on the order of a few nanoseconds after absorbing the illuminating optical energy), the molecule responds by emitting optical energy at a longer wavelength (i.e., lower energy state) than the exciting/illuminating energy. For example, blood constituents bilirubin and carotenoid chromophores are known to fluoresce in the spectral region near 450 nanometers when optically excited (illuminated) at 340 nanometers. Fluorescence form these molecules may be used to locate the position of underlying blood vessels as follows. Thelight source313 inFIG. 3A may be chosen to emitoptical radiation311 near 340 nanometers (corresponding to the absorption band of bilirubin for example) which may be coupled intooptical fiber310 which guides theoptical radiation311 to the patient'sskin surface304. Theoptical radiation311 may penetrate through the patient'sskin304, traverse the blood vessel wall, enter the patient's blood stream and eventually interact (be absorbed by) abilirubin molecule314 present in the patient's blood stream. Thereafter, thebilirubin molecule314 may re-radiate a fluorescent optical signal316 (see the expanded view of thefiber310 shown inFIG. 3B), a portion of which may be coupled back into theoptical fiber310 and guided back toward thelight source313. The returningfluorescent signal316 may be reflected bypartial mirror318 tooptical detector320 which may have optical filters embedded to only respond to the340 nanometer signal indicative of bilirubin/blood fluorescence. In this configuration, theoptical detector320 would receive the maximum fluorescent signal back from thebilirubin molecule314, when thecatheter302/fiber310 device is directly placed over the underlyingblood vessel306.
• For example,FIG. 4 shows a top view (looking down on the device depicted inFIG. 3) of thecatheter402 depicting thefiber410 inserted in the working channel on the right hand side of thecatheter402. The catheter is shown displaced vertically, i.e., off-set from directly over the underlyingblood vessel406, and as such the fluorescent signal316 (fromFIG. 3) capture by theoptical fiber410 will be relatively small. However, when the catheter is translated down directly over the blood vessel (seeFIG. 5), thecatheter502 can be manually positioned back-and-forth until a maximum fluorescent signal316 (FIG. 3) is detected by theoptical detector320 signifying theblood vessel506 has been located. This process can be repeated at several adjacent points to delineate the course of the vessel subcutaneously and further aid with correct insertion.
• As noted above, the present invention is directed generally to medical devices and more particularly to a light-guided catheter with inside-out transcutaneous illumination and visualization of placement through the skin including a method to locate non-visible blood vessels for catheterization.
• The present invention should not be considered limited to the particular examples described above, but rather should be understood to cover all aspects of the invention as fairly set out in the attached claims. Various modifications, equivalent processes, as well as numerous structures to which the present invention may be applicable will be readily apparent to those of skill in the art to which the present invention is directed upon review of the present specification. The claims are intended to cover such modifications and devices.

Claims (22)

1. A method for transcutaneous viewing and guiding of intracorporeal catheters into a body, comprising the steps of:

a) inserting a catheter having at least one lumen, into the body; and

b) illuminating said catheter along at least a portion of its lateral surface length with a signal which would be capable of propagating through blood and tissue to an external viewer or detector outside of the body, so that the viewer can detect at least a partial length of the catheter within the body.

2. The method ofclaim 1 further including the step of inserting into the lumen a source of visible illumination capable of propagating through blood and tissue to an external viewer or detector outside of the body.

3. The method ofclaim 1 wherein said internally illuminated catheter emits light of first color and further includes the step of inserting into the lumen a second source of illumination of a second color different from said first color, both of said colors being capable of propagating through blood and tissue to an external viewer outside of the body, whereby the location of each illumination source can be discerned from outside the body.

4. The method ofclaim 1 wherein the catheter is made of a material opaque to visible light and the light emitting device extends beyond the distal end of the catheter.

5. A method of locating non-visible intracorporeal/ blood vessels for catheterization comprising the steps of;

a. illuminating candidate locations with light capable of inducing fluorescence from blood constituents; and

b. detecting responsive fluorescent response from said blood constituents; and

c. selecting potential site for catheterization based upon detection of a predetermined fluorescent signal.

6. A transcutaneously viewable catheter comprising;

a. a tubular member having an insertable end and a first channel along the length of said catheter;

b. a removable illumination source in said channel having at least an illuminated end, said source being configured to be extendible through said channel and beyond said end so that when said source is inserted into the channel, the illumination is visible outside the body, and the end thereof can be visually located.

7. The apparatus ofclaim 6 wherein said tubular member is substantially opaque to light from the illumination source; so that when said removable source is extended beyond end of the member, the illumination is visible outside the body.

8. The apparatus ofclaim 6 wherein said tubular member is partially transparent to light emitted by said illumination source; so that when said illumination source reaches the end of tubular member, an observer can detect the difference in level, pattern, or wavelength of light transmission as the illumination source exits the tubular member.

9. The apparatus ofclaim 6 wherein said illumination source is leaky and emits light along at least a portion of its length.

10. The apparatus ofclaim 9 wherein said illumination source emits light of a different intensity, pattern, or wavelength at its end than elsewhere therealong, so that it is possible to easily discern its path and end from outside the body.

11. An apparatus for locating substantially non-visible intracorporeal/ blood vessels for catheterization comprising;

a) a tubular member having an insertable end and a channel along the length thereof;

b) a removable illumination source insertable in said channel having an illuminated end configured to be extendible through said channel;

c) an illumination source capable of emitting light of a predetermined optical wavelengths to excite fluorescence from blood constituents;

d) an optical channel to receive fluorescence from blood constituents; and

e) an optical detector coupled to the optical channel to measure fluorescence from blood constituents.

12. The apparatus ofclaim 11 wherein the illumination source comprises a low-loss fiber optic conductor.

13. The apparatus ofclaim 11 wherein the illumination source comprises a light emitting diode emitting at least visible light.

14. The apparatus ofclaim 11 wherein the optical channel simultaneously delivers the illumination energy to excite fluorescence and receives fluorescence from blood constituents.

15. The apparatus ofclaim 10 wherein the optical components include a separator to separate illumination and fluorescence signals prior to the optical detector.

16. The apparatus ofclaim 15 wherein the separator is a dichroic mirror.

17. A transcutaneously viewable or detectable catheter comprising;

a. a tubular member having an insertable end

b. a first channel along the length of said catheter

c. a first fiber optic having an end and being formed within said tubular member and running substantially the length thereof; at least a portion of said optic being leaky; and

d. a first illumination source being connectable to said first optic to provide illumination at least along a portion of the length of the catheter with a first predetermined color of light; and

so that the illumination is visible outside the body.

18. The catheter ofclaim 17 further including second fiber optic having an end and being insertable through said first channel and being likewise attachable to a source of illumination, said second optic being illuminated with a color distinguishable from the first color which said first optic is illuminated, so that the location of the end of said second optic can be distinguished from said first optic.

19. The catheter ofclaim 18 wherein said second optic is only leaky in a region extending from its end and a portion extending therefrom.

20. The catheter ofclaim 17 further including a second fiber optic having an end and being formed within said tubular member and running substantially the length thereof; at least a portion of said optic being leaky proximate its end and a portion extending therefrom; and

a second illumination source being connectable to said second optic to provide illumination to said leaky portion, said second source providing a illumination color different from said the color of said first source; whereby the end of said second optic can be visually distinguished from said first optic.

21. The catheter ofclaim 17 further including an elongated radio opaque element having an end and being insertable through said first channel; so that the location of the end of said elongated element can be distinguished from said first optic and detected from outside the body.

22. The catheter ofclaim 21 wherein said element includes a second fiber optic along at least a portion of the element; so that the location of said element can be detected either visually or by radio detection.

Images